Skip to main content
Bertram Pitt, MD, Cardiology, Ann Arbor, MI

BertramPittMD

Cardiology Ann Arbor, MI

Adult Congenital Heart Disease, Heart Failure & Transplantation, Preventive Cardiology

Physician

Dr. Pitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pitt's full profile

Already have an account?

  • Office

    1500 East Medical Center Dr
    3rd Floor Cardiovascular Center
    Ann Arbor, MI 48109
    Phone+1 888-287-1082
  • Is this information wrong?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1966 - 1966
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1960 - 1963
  • Mount Sinai Beth Israel Hospital
    Mount Sinai Beth Israel HospitalInternship, Transitional Year, 1959 - 1960
  • University of Basel Faculty of Medicine
    University of Basel Faculty of MedicineClass of 1959

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1978 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure  
    Deepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes  
    Bertram Pitt, MD, The New England Journal of Medicine
  • Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction  
    Bertram Pitt, JACC: Cardiovascular Imaging
  • Join now to see all

Lectures

  • Heart Failure 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Oxford University Press Has Registered This DOI Pre-PublicationOctober 2018
  • Declining Risk of Sudden Death in Heart FailureJuly 2017
  • The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure — NEJMSeptember 1999

Press Mentions

  • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript
    Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call TranscriptMarch 6th, 2023
  • New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure
    New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart FailureNovember 6th, 2022
  • Finerenone: ‘Striking’ Cut in Pneumonia, COVID-19 Risks
    Finerenone: ‘Striking’ Cut in Pneumonia, COVID-19 RisksOctober 27th, 2022
  • Join now to see all

Professional Memberships